SWS Hemodialysis Care Co., Ltd.

About: SWS Hemodialysis Care Co., Ltd. ("SWS"), founded in 2001, offers comprehensive blood purification solutions that improve care for patients with kidney failure and critically ill patients worldwide. Our products and services include blood purification devices, consumables, intelligent dialysis management systems, and dialysis center services. SWS is publicly registered on the Shanghai Stock Exchange's STAR Market (SSE: 688410), the first company in the blood purification industry in China. As a fully industrialized company, SWS has three subsidiaries: TWT Bio-tech, KMJ Dialysis Co., Ltd., and a Chinese-Swiss joint venture SD Medical, specializing in world-class dialyzers. Innovation is embedded in the DNA of SWS. Over the past two decades, SWS has ensured the safety of key technologies, research, and engineering methods for blood purification. We hold independent intellectual property rights and hundreds of authorized patents. Recognized as a national demonstration enterprise for technological innovation, SWS has established technological and engineering research centers, as well as a national post-doctoral workstation. As a market pioneer in China, SWS has also participated in the development of three national standards and five industry standards. Improving patient health is SWS's highest priority and ultimate goal. Enhanced patient care has been made possible through our commitment to integrated blood purification technology. With thousands of devices installed worldwide, many kidney disease patients have benefited from our quality products and specialized services. SWS devices are CE marked, and the quality system is certified to ISO 13485:2016. SWS has been recognized as one of the most reliable partners by top-tier Class A Chinese hospitals and international medical institutions in over 80 countries and regions.